A Study of Rituximab (MabThera®/Rituxan®) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate

NCT00578305 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

185

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL: Rituximab
DRUG: Placebo
DRUG: Methylprednisolone
DRUG: Methotrexate
DRUG: Folic acid or folate

Sponsor

Hoffmann-La Roche